Literature DB >> 3561710

The coexistence of myasthenia gravis and myotonic dystrophy in one family.

J Maytal, A J Spiro, S Sinnar, S L Moshe.   

Abstract

We are reporting the unique coexistence of two distinct neuromuscular diseases, myotonic dystrophy and the juvenile form of myasthenia gravis, occurring in one family. A 16-month-old previously healthy female presented with a two month history of bilateral varying drooping of both eyelids and bilateral external ophthalmoparesis. The acetylcholine receptor antibodies were elevated, and there was a dramatic response to edrophonium confirming the clinical impression of myasthenia gravis. Spontaneous remission of the ptosis was noted after six months with no specific treatment. Many other family members were examined; none of them had clinical or laboratory evidence of myasthenia gravis. The clinical examination of the mother and the maternal grandmother, neither of whom had any complaints, resulted in a definite diagnosis of myotonic dystrophy. The proband's father and a 3-year-old sister were examined and found to be normal. We studied the HLA antigens of all of the available family members; none were found to have the HLA antigens most commonly associated with myasthenia gravis. Secretor gene studies were not helpful in providing additional genetic identification. The question generated by the coexistence of these two uncommon disorders in one family is if there is a genetic or other relationship between them or if this was merely a coincidental occurrence. At this point in time the question remains unanswered and must await demonstration of additional similar circumstances.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3561710     DOI: 10.1055/s-2008-1052426

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  1 in total

1.  The coexistence of myasthenia gravis and myotonic dystrophy type 2 in a single patient.

Authors:  Ana Nikolic; Vidosava Rakocevic Stojanovic; Stanka Romac; Dusanka Savic; Ivana Basta; Dragana Lavrnic
Journal:  J Clin Neurol       Date:  2013-04-04       Impact factor: 3.077

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.